List view / Grid view
AstraZeneca and Bristol-Myers Squibb Company today announced that the US Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes in adults. KOMBIGLYZE XR is the first and only once-a-day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering strong glycaemic control across…
4 November 2010 | By The Scott Partnership
Enable Pharmaceutical Manufacturers to Perform Easy and Reliable Transmembrane Protein Characterization...
4 November 2010 | By kdm communications limited
JAX to distribute mouse models created using proprietary ZFN technology...
3 November 2010 | By The Scott Partnership
Quotient Bioresearch, has officially opened its new, state-of-the-art radiochemistry facility in Cardiff...
3 November 2010 | By The Scott Partnership
PRECOS, announces its official launch following its spin-out from the University of Nottingham...
3 November 2010 | By The Scott Partnership
Prism Ideas, announced that the company will be collaborating with the University of Liverpool...
2 November 2010 | By The Scott Partnership
Molecular Profiles announces it is to demonstrate its expansion of capabilities at the upcoming AAPS / FIP Pharmaceutical Sciences World Congress 2010, booth # 712...
1 November 2010 | By M:Communications
Medivir AB, is pleased to announce the appointment of Charlotte Edenius to the new position of Vice President, Research & Development Projects, effective 1 November...
29 October 2010 | By Premier Research Group Limited
Premier Research Group Limited, announces the appointment of Ludo Reynders, Ph.D. to the position of Chief Executive Officer...
29 October 2010 | By AstraZeneca
AstraZeneca announced an agreement with Daiichi Sankyo for the co-promotion and supply of NEXIUM, a proton pump inhibitor...
27 October 2010 | By The Scott Partnership
Exco InTouch, has been recognised for its tremendous strides in the delivery of electronic Patient Reported Outcomes (ePRO) solutions...
27 October 2010 | By kdm communications limited
Sigma Life Science, today announced a partnership between its SAGE Labs division...
27 October 2010 | By College Hill Ltd
Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine is pleased to announce the appointment of Susan Lowther as Chief Financial Officer.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of a new online demonstration of its TSQ Module™ software for Watson™ laboratory information management system (LIMS).
Thermo Fisher Scientific Inc., the world leader in serving science, and Proteome Sciences plc (LSE: PRM), a leading provider of protein biomarker services, today announced the companies will collaborate to deliver innovative products for protein biomarker research.
